InvestorsHub Logo
Followers 4
Posts 1201
Boards Moderated 0
Alias Born 01/08/2018

Re: None

Sunday, 03/17/2019 3:36:26 PM

Sunday, March 17, 2019 3:36:26 PM

Post# of 34588
Cronos Group's $1.8 Billion Investment From Altria Has Closed. Now What?

Third and finally, Cronos will need to continue to diversify its product portfolio away from lower margin dried cannabis flower. The company's $100 million partnership with Ginkgo Bioworks, which allows Cronos access to Ginkgo's microorganism platform for the development of yeast strains capable of commercial cannabinoid production, is a perfect example of a high-margin venture Wall Street will cheer. Cronos needs to find at least one more alternative product it can push, other than dried cannabis, if it has any chance of maintaining its lofty valuation.

The "heat is on", as it were.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News